National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing Medical University, Nanjing, China; the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China.
National Clinical Research Center for Kidney Diseases, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
J Biol Chem. 2024 Aug;300(8):107516. doi: 10.1016/j.jbc.2024.107516. Epub 2024 Jul 1.
Focal segmental glomerulosclerosis (FSGS), a common cause of primary glomerulonephritis, has a poor prognosis and is pathologically featured by tubulointerstitial injury. Thrombospondin-1 (TSP-1) is an extracellular matrix protein that acts in combination with different receptors in the kidney. Here, we analyzed the tubular expression of TSP-1 and its receptor integrin β3 (ITGB3) in FSGS. Previously the renal interstitial chip analysis of FSGS patients with tubular interstitial injury showed that the expression of TSP-1 and ITGB3 were upregulated. We found that the expression of TSP-1 and ITGB3 increased in the tubular cells of FSGS patients. The plasma level of TSP-1 increased and was correlated to the degree of tubulointerstitial lesions in FSGS patients. TSP-1/ITGB3 signaling induced renal tubular injury in HK-2 cells exposure to bovine serum albumin and the adriamycin (ADR)-induced nephropathy model. THBS1 KO ameliorated tubular injury and renal fibrosis in ADR-treated mice. THBS1 knockdown decreased the expression of KIM-1 and caspase 3 in the HK-2 cells treated with bovine serum albumin, while THBS1 overexpression could induce tubular injury. In vivo, we identified cyclo-RGDfK as an agent to block the binding of TSP-1 to ITGB3. Cyclo-RGDfK treatment could alleviate ADR-induced renal tubular injury and interstitial fibrosis in mice. Moreover, TSP-1 and ITGB3 were colocalized in tubular cells of FSGS patients and ADR-treated mice. Taken together, our data showed that TSP-1/ITGB3 signaling contributed to the development of renal tubulointerstitial injury in FSGS, potentially identifying a new therapeutic target for FSGS.
局灶节段性肾小球硬化症(FSGS)是原发性肾小球肾炎的常见病因,预后较差,其病理特征为肾小管间质损伤。血小板反应蛋白-1(TSP-1)是一种细胞外基质蛋白,与肾脏中的不同受体结合发挥作用。在这里,我们分析了 FSGS 患者中 TSP-1 及其受体整合素β3(ITGB3)的肾小管表达。先前 FSGS 患者伴肾小管间质损伤的肾间质芯片分析显示,TSP-1 和 ITGB3 的表达上调。我们发现 FSGS 患者肾小管细胞中 TSP-1 和 ITGB3 的表达增加。TSP-1 的血浆水平升高,并与 FSGS 患者肾小管间质病变的程度相关。TSP-1/ITGB3 信号在 HK-2 细胞暴露于牛血清白蛋白和阿霉素(ADR)诱导的肾病模型中诱导肾小管损伤。THBS1 KO 改善了 ADR 处理小鼠的肾小管损伤和肾纤维化。THBS1 敲低降低了牛血清白蛋白处理的 HK-2 细胞中 KIM-1 和 caspase 3 的表达,而 THBS1 过表达可诱导肾小管损伤。在体内,我们鉴定出环-RGDfK 作为一种阻止 TSP-1 与 ITGB3 结合的药物。环-RGDfK 处理可减轻 ADR 诱导的小鼠肾小管损伤和间质纤维化。此外,TSP-1 和 ITGB3 在 FSGS 患者和 ADR 处理的小鼠的肾小管细胞中发生共定位。总之,我们的数据表明 TSP-1/ITGB3 信号参与 FSGS 中肾小管间质损伤的发生,可能为 FSGS 确定了一个新的治疗靶点。